RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Meridian Bioscience Stock

Meridian Bioscience ROCE 2024

Meridian Bioscience ROCE

0.21

Ticker

VIVO

ISIN

US5895841014

WKN

871583

In 2024, Meridian Bioscience's return on capital employed (ROCE) was 0.21, a -33.78% increase from the 0.31 ROCE in the previous year.

Meridian Bioscience Aktienanalyse

What does Meridian Bioscience do?

Meridian Bioscience Inc. is a global company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. The company was founded in 1976 by William J. Motto and initially focused on the development of enzyme immunoassays (EIA). Over the years, the company has grown and diversified its product offerings, becoming a leading provider of diagnostic test kits for acute and chronic medical conditions, infectious diseases, gastrointestinal infections, and virology. The company's success is attributed to its diverse range of test kits in various medical areas, including immunology, infectious diseases, sexually transmitted diseases, gastroenterology, and virology. Additionally, Meridian Bioscience Inc. stays up-to-date with the latest technological advancements in biotechnology to ensure the fast and effective performance of its tests. The company operates globally, collaborating with universities, research institutions, government agencies, and distributors to ensure the worldwide distribution and marketing of its products. In summary, Meridian Bioscience Inc. is an innovative company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. Its wide range of products, including immunology products, infectious disease diagnostics, sexually transmitted disease test kits, gastroenterology, virology, and molecular diagnostics, coupled with advanced technologies, provides fast, accurate, and reliable diagnostic support. Meridian Bioscience ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Meridian Bioscience's Return on Capital Employed (ROCE)

Meridian Bioscience's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Meridian Bioscience's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Meridian Bioscience's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Meridian Bioscience’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Meridian Bioscience stock

What is the ROCE (Return on Capital Employed) of Meridian Bioscience this year?

The ROCE of Meridian Bioscience is 0.21 undefined this year.

How has the ROCE (Return on Capital Employed) of Meridian Bioscience developed compared to the previous year?

The ROCE of Meridian Bioscience has increased by -33.78% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Meridian Bioscience?

A high Return on Capital Employed (ROCE) indicates that Meridian Bioscience has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Meridian Bioscience?

A low ROCE (Return on Capital Employed) can indicate that Meridian Bioscience has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Meridian Bioscience impact the company?

An increase in the ROCE of Meridian Bioscience can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Meridian Bioscience affect the company?

A decrease in ROCE of Meridian Bioscience can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Meridian Bioscience?

Some factors that can affect Meridian Bioscience's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Meridian Bioscience so important for investors?

The ROCE of Meridian Bioscience is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Meridian Bioscience take to improve the ROCE?

To improve the ROCE, Meridian Bioscience can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Meridian Bioscience pay?

Over the past 12 months, Meridian Bioscience paid a dividend of 0.13 USD . This corresponds to a dividend yield of about 0.37 %. For the coming 12 months, Meridian Bioscience is expected to pay a dividend of 0.51 USD.

What is the dividend yield of Meridian Bioscience?

The current dividend yield of Meridian Bioscience is 0.37 %.

When does Meridian Bioscience pay dividends?

Meridian Bioscience pays a quarterly dividend. This is distributed in the months of June, September, December, March.

How secure is the dividend of Meridian Bioscience?

Meridian Bioscience paid dividends every year for the past 3 years.

What is the dividend of Meridian Bioscience?

For the upcoming 12 months, dividends amounting to 0.51 USD are expected. This corresponds to a dividend yield of 1.51 %.

In which sector is Meridian Bioscience located?

Meridian Bioscience is assigned to the 'Health' sector.

Wann musste ich die Aktien von Meridian Bioscience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Meridian Bioscience from 2/14/2019 amounting to 0.125 USD, you needed to have the stock in your portfolio before the ex-date on 2/1/2019.

When did Meridian Bioscience pay the last dividend?

The last dividend was paid out on 2/14/2019.

What was the dividend of Meridian Bioscience in the year 2023?

In the year 2023, Meridian Bioscience distributed 0 USD as dividends.

In which currency does Meridian Bioscience pay out the dividend?

The dividends of Meridian Bioscience are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Meridian Bioscience stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Meridian Bioscience

Our stock analysis for Meridian Bioscience Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Meridian Bioscience Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.